Fil LTD Beam Therapeutics Inc. Transaction History

Fil LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $48.6 Million - $70.8 Million	-715,098 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $60.3 Million - $95.5 Million	715,098 New	715,098 $62.2 Million
Q1 2021 May 14, 2021	SELL	$71.28 - $120.75 $58 Million - $98.2 Million	-813,389 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$22.24 - $95.63 $60,648 - $260,783	-2,727 Reduced 0.33%	813,389 $66.4 Million
Q3 2020 Nov 13, 2020	SELL	$19.0 - $30.57 $15.4 Million - $24.8 Million	-810,663 Reduced 49.83%	816,116 $20.1 Million
Q1 2020 May 14, 2020	BUY	$13.31 - $29.2 $21.7 Million - $47.5 Million	1,626,779 New	1,626,779 $29.3 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.